Delivery of neurotrophin-3 by RVG-Lamp2b-modified mesenchymal stem cell-derived exosomes alleviates facial nerve injury
- PMID: 38858338
- DOI: 10.1007/s13577-024-01086-7
Delivery of neurotrophin-3 by RVG-Lamp2b-modified mesenchymal stem cell-derived exosomes alleviates facial nerve injury
Abstract
We aim to investigate the effect of RVG-Lamp2b-modified exosomes (exos) loaded with neurotrophin-3 (NT-3) on facial nerve injury. Exos were collected from control cells (Ctrl Exo) or bone marrow mesenchymal stem cells co-transfected with RVG-Lamp2b and NT-3 plasmids (RVG-NT-3 Exo) by gradient centrifugation and identified by western blotting, transmission electron microscopy, and nanoparticle tracking analysis. Effect of RVG-NT-3 Exo on oxidative stress damage was determined by analysis of the morphology, viability, and ROS production of neurons. Effect of RVG-NT-3 Exo on facial nerve axotomy (FNA) was determined by detecting ROS production, neuroinflammatory reaction, microglia activation, facial motor neuron (FMN) death, and myelin sheath repair. Loading NT-3 and modifying with RVG-Lamp2b did not alter the properties of the exos. Moreover, RVG-NT-3 Exo could effectively target neurons to deliver NT-3. Treatment with RVG-NT-3 Exo lowered H2O2-induced oxidative stress damage in primary neurons and Nsc-34 cells. RVG-NT-3 Exo treatment significantly decreased ROS production, neuroinflammatory response, FMN death, and elevated microglia activation and myelin sheath repair in FNA rat models. Our findings suggested that RVG-NT-3 Exo-mediated delivery of NT-3 is effective for the treatment of facial nerve injury.
Keywords: Facial motor neuron; Facial paralysis; Microglia; NT-3; RVG-Lamp2b.
© 2024. The Author(s) under exclusive licence to Japan Human Cell Society.
Similar articles
-
Exosomes derived from human umbilical cord mesenchymal stem cells loaded with RVG-Lamp2b and Netrin-1 promotes Schwann cell invasion and migration.Tissue Cell. 2023 Dec;85:102219. doi: 10.1016/j.tice.2023.102219. Epub 2023 Sep 11. Tissue Cell. 2023. PMID: 37716176
-
Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy.J Biomed Nanotechnol. 2019 Dec 1;15(12):2401-2412. doi: 10.1166/jbn.2019.2866. J Biomed Nanotechnol. 2019. PMID: 31748020
-
Neuroprotective effects of exosomes derived from bone marrow mesenchymal stem cells treated by Musk Ketone on ischemic stroke.J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107628. doi: 10.1016/j.jstrokecerebrovasdis.2024.107628. Epub 2024 Feb 9. J Stroke Cerebrovasc Dis. 2024. PMID: 38342273
-
[Exosomes from ectoderm mesenchymal stem cells inhibits lipopolysaccharide-induced microglial M1 polarization and promotes survival of H2O2-exposed PC12 cells by suppressing inflammatory response and oxidative stress].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jan 20;44(1):119-128. doi: 10.12122/j.issn.1673-4254.2024.01.14. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 38293983 Free PMC article. Chinese.
-
Exosomes Derived from miR-214-Enriched Bone Marrow-Derived Mesenchymal Stem Cells Regulate Oxidative Damage in Cardiac Stem Cells by Targeting CaMKII.Oxid Med Cell Longev. 2018 Aug 7;2018:4971261. doi: 10.1155/2018/4971261. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30159114 Free PMC article.
Cited by
-
Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy.J Ovarian Res. 2025 May 5;18(1):95. doi: 10.1186/s13048-025-01672-9. J Ovarian Res. 2025. PMID: 40325478 Free PMC article.
References
-
- Schroeter F, Amyai N, Petignat PA, Wicki B. Facial palsy: diagnostic traps. Revue medicale suisse. 2023;19(836):1413–8. https://doi.org/10.53738/revmed.2023.19.836.1413 . - DOI - PubMed
-
- Kinoshita I, Kawata R, Higashino M, Terada T, Haginomori SI, Tochizawa T. Tumor localization is the important factor for recovery time of postoperative facial nerve paralysis in benign parotid surgery. Auris Nasus Larynx. 2023;51(1):214–20. https://doi.org/10.1016/j.anl.2023.07.002 . - DOI - PubMed
-
- Zhou Y, Dong X, Xing Y, Wang R, Yang S, Han Y, et al. Effects of electroacupuncture therapy on intractable facial paralysis: a systematic review and meta-analysis. PLoS ONE. 2023. https://doi.org/10.1371/journal.pone.0288606 . - DOI - PubMed - PMC
-
- Tawfik HA, Dutton JJ. Facial nerve palsy and the eye: etiology, diagnosis, and management. Int Ophthalmol Clin. 2023;63(3):75–94. https://doi.org/10.1097/iio.0000000000000457 . - DOI - PubMed
-
- Lee JM, Choi YJ, Yoo MC, Yeo SG. Central facial nervous system biomolecules involved in peripheral facial nerve injury responses and potential therapeutic strategies. Antioxidants (Basel, Switzerland). 2023;12(5):1036. https://doi.org/10.3390/antiox12051036 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials